Vertex Pharmaceuticals VRTX Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $12B+8.9% | $11.02B+11.7% | $9.87B+10.5% | $8.93B+17.9% | ||
| $1.65B+7.9% | $1.53B+21.3% | $1.26B+16.8% | $1.08B+19.5% | ||
| $10.35B+9.1% | $9.49B+10.3% | $8.61B+9.6% | $7.85B+17.7% | ||
| 86.2%+0.1pp | 86.1%-1.1pp | 87.2%-0.7pp | 87.9%-0.2pp | ||
| $1.75B+19.7% | $1.46B+28.8% | $1.14B+20.3% | $944.7M+12.5% | ||
| $7.83B-30.4% | $11.25B+86.4% | $6.04B+30.6% | $4.62B-3.5% | ||
| $4.17B— | —— | $3.83B-11.0% | $4.31B+54.8% | ||
| 34.8%— | —— | 38.8%-9.4pp | 48.2%+11.5pp | ||
| $4.64B+1,768% | $248.5M-94.3% | $4.38B+3.5% | $4.23B+55.0% | ||
| $690M-12.0% | $784.1M+3.1% | $760.2M-16.5% | $910.4M+134% | ||
| $3.95B— | —— | $3.62B+9.0% | $3.32B+41.8% | ||
| 32.9%— | —— | 36.7%-0.5pp | 37.2%+6.3pp | ||
| $15.32— | —— | $13.89+8.3% | $12.82+42.3% | ||
| $4.38B+4,904% | $87.6M-97.8% | $4.01B-9.9% | $4.46B+53.2% | ||
| 36.5%+35.7pp | 0.8%-39.9pp | 40.7%-9.2pp | 49.9%+11.5pp | ||
| $4.17B+3,589% | -$119.6M-103% | $3.83B-11.0% | $4.31B+54.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Vertex Pharmaceuticals's revenue?
- Vertex Pharmaceuticals (VRTX) generated $12.2B in revenue over the trailing twelve months, up 10.1% year over year.
- Is Vertex Pharmaceuticals profitable?
- Vertex Pharmaceuticals reported $4.3B in net income over the trailing twelve months, a 35.5% net margin.
- What are Vertex Pharmaceuticals's profit margins?
- Gross margin is 86.2% and operating margin is 38.3%, with a 35.5% net margin.
- What is Vertex Pharmaceuticals's earnings per share?
- Vertex Pharmaceuticals's diluted EPS over the trailing twelve months is $16.85.
- Where does Vertex Pharmaceuticals's income statement data come from?
- Every line is extracted from Vertex Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
